- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0106653

About Trilend Pharmaceuticals Private Limited
Data last updated:
Trilend Pharmaceuticals Private Limited is a private limited company based in Mahemdavad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2019PTC106321. Its GSTIN is 24AAHCT1470F1ZK (Gujarat).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹11.1 Lakh. It is led by directors including Suhas Ishvarlal Patel and Alpeshkumar Kantilal Patel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Mahemdavad, Gujarat.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.24 Cr, a growth of 72% compared to the previous year. For the same year it recorded a net loss of ₹72.72 Lakh (net margin -32.5%) and EBITDA of ₹33.1 Lakh (EBITDA margin 14.8%).
As per MCA filings, the company has open charges of ₹11.55 Cr on record.
Trilend Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0106653). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website trilendpharmaceuticals.com.
Company details
Recognitions & Rankings of Trilend Pharmaceuticals
Contact details
Trilend Pharmaceuticals Private Limited's registered office is in Mahemdavad, Gujarat. Its website is trilendpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressSurvey No – 339/2 Village Kuna, Taluka Mahemdabad Kheda, Mahemdavad, Gujarat, India – 387110
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Trilend Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Trilend Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Trilend Pharmaceuticals Private Limited, buy the company report.
Financials of Trilend Pharmaceuticals Private Limited
FY 2024 filings availableTrilend Pharmaceuticals Private Limited reported revenue of ₹2.24 Cr (up 72% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 72% in the latest year. EBITDA rose 165% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹2.24 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹72.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.8% | ||||
| Net Profit Margin | -32.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Trilend Pharmaceuticals Private Limited, buy the company report.
Board of directors of Trilend Pharmaceuticals Private Limited
Trilend Pharmaceuticals has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Jasvantbhai Patel Also directs: Accent Microcell Limited, Aneta Pharmaceuticals Private Limited, Antelp Corporation Private Limited and 3 more | Additional Director | 12 May 2025 | 1 Years 5 Months | Current |
| Suhas Ishvarlal Patel | Director | 27 Jul 2023 | 3 Years 3 Months | Current |
| Alpeshkumar Kantilal Patel Also directs: Siddhanath Drytech LLP, Lourish Food Private Limited | Director | 29 Mar 2019 | 7 Years 7 Months | Current |
| Pareshbhai Hirabhai Patel | Director | 29 Mar 2019 | 7 Years 7 Months | Current |
| Ankurkumar Hasmukhbhai Patel | Additional Director | 12 May 2025 | 1 Years 5 Months | Current |
Auditor
Trilend Pharmaceuticals Private Limited is audited by J R Gajera & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J R Gajera & Associates | FY 2024 | 141388 |
Shareholding
The shareholding of Trilend Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Trilend Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2025 | 101175099 | Hdfc Bank Limited | ₹7.85 Cr | Open | |
| 23 Nov 2021 | 100520551 | Others | ₹3.6 Cr | Open | |
| 23 Nov 2021 | 100520186 | Others | ₹10 Lakh | Open |
To see the full charge records of Trilend Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Trilend Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trilend Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Trilend Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAHCT1470F1ZK | Gujarat | Active | 20 Mar 2019 |
To see the full GST registrations and return filing status of Trilend Pharmaceuticals Private Limited, buy the company report.
Recent activity
Trilend Pharmaceuticals Private Limited has 15 board changes on record since 2019: 6 appointments and 9 cessations. The latest: Jitesh Dhanjibhai Thummar ceased to be Director on 10 Jun 2025.
11 earlier events are in the company report.
Frequently asked questions
Trilend Pharmaceuticals is an active private limited company based in Mahemdavad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 January 2019 (7+ years old) and is registered under CIN U24100GJ2019PTC106321.
Trilend Pharmaceuticals has 5 current directors:
- Nitin Jasvantbhai Patel - Additional Director
- Suhas Ishvarlal Patel - Director
- Alpeshkumar Kantilal Patel - Director
- Pareshbhai Hirabhai Patel - Director
- Ankurkumar Hasmukhbhai Patel - Additional Director
The latest financial statements of Trilend Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Trilend Pharmaceuticals is 24AAHCT1470F1ZK, registered in Gujarat.
The CIN (Corporate Identification Number) of Trilend Pharmaceuticals is U24100GJ2019PTC106321. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trilend Pharmaceuticals was incorporated on 29 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Jitesh Dhanjibhai Thummar ceased to be Director on 10 Jun 2025. Momin Iqbalali Abbasbhai ceased to be Director on 10 Jun 2025. Ankurkumar Hasmukhbhai Patel was appointed as Additional Director on 12 May 2025. Trilend Pharmaceuticals has 15 board changes on record in total.
Yes, Trilend Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0106653).
Trilend Pharmaceuticals can be reached through the website trilendpharmaceuticals.com. Its registered office is in Mahemdavad, Gujarat, India.
The registered office of Trilend Pharmaceuticals is at Survey No – 3392 Village Kuna, Taluka Mahemdabad Kheda, Mahemdavad, Gujarat, India – 387110.

